Mode
Text Size
Log in / Sign up

1-Hz TMS targeting right dlPFC reduced amygdala reactivity and PTSD symptoms in 50 adults with PTSD symptoms compared with shamPersonalized Brain Stimulation Shows Promise For Long Term PTSD Relief

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider 1-Hz TMS targeting right dlPFC for personalized neuromodulation in PTSD, noting mixed skin conductance results and lack of safety data.

This randomized clinical trial evaluated 50 adults with PTSD symptoms. The intervention involved 1-Hz TMS delivered to an fMRI-guided target within the right dorsolateral prefrontal cortex with the strongest functional connection to the right amygdala. The comparator was sham TMS. Follow-up occurred between 3 and 6 months after TMS.

Active TMS significantly reduced right amygdala threat reactivity compared with sham TMS. No significant effect of TMS was observed for skin conductance reactivity. Significant reductions in hyperarousal and total PTSD symptoms were observed across groups from pre- to post-TMS. At follow-up, Active TMS significantly reduced symptoms compared with sham TMS for hyperarousal and total PTSD symptoms.

Safety data were not reported. Serious adverse events, discontinuations, and tolerability were not reported. The study did not report p-values or confidence intervals for the main results. Limitations include the small sample size of 50 participants and the lack of reported funding or conflicts of interest.

These findings suggest the potential for a personalized approach to neuromodulation in individuals with PTSD. The evidence is limited by the absence of statistical precision and the short-term nature of the follow-up period.

Many people live with a constant sense of danger even when they are safe. They wake up with racing hearts and feel overwhelmed by memories that should be in the past. This is the reality for millions of adults dealing with posttraumatic stress disorder.

Current treatments often involve therapy or medication that helps some people but leaves others stuck. Doctors have tried many methods to calm the brain but results vary wildly from person to person. This uncertainty makes it hard for patients to know which path will work for them.

A Brain Map Guides The Treatment

Scientists have developed a new way to aim brain treatment more precisely. They use magnetic pulses to change how specific parts of the brain talk to each other. The key is finding the exact spot that controls fear responses.

In the past, doctors used a standard map to guess where to place the device. This one-size-fits-all approach often missed the mark for many patients. The new method uses a brain scan to find the perfect target first.

Why The Fear Center Matters

The amygdala is a small part of the brain that acts like an alarm system. It sounds the warning bell when it senses danger or threat. In people with PTSD, this alarm gets stuck in the on position.

The new treatment uses imaging to find the best wire to cut that alarm. Researchers connected the alarm to a switch in the prefrontal cortex. This switch can turn down the volume of the fear signal.

Think of it like a lock and key. The old method tried many keys to open the door. The new method scans the lock to make a custom key that fits perfectly. This precision helps the treatment work better for the individual.

What Changed After Six Months

Fifty adults with PTSD symptoms took part in this clinical trial. They were randomly assigned to get real treatment or a fake version that felt the same. The real treatment involved ten sessions over a few weeks.

Doctors measured brain activity before and after the sessions using a scanner. They also tracked how much the patients felt their symptoms improved. The goal was to see if the personalized approach worked better than the standard one.

This personalized approach is not yet available in most clinics.

The results showed that the active treatment lowered activity in the fear center. The brain scans confirmed the alarm system was less reactive after the sessions. This physical change matched what patients reported feeling in their daily lives.

Patients who got the real treatment saw their symptoms stay lower for months. Those in the fake group improved at first but their symptoms came back. The personalized method seemed to create a lasting change in the brain wiring.

But The Catch Remains Clear

Not every measure of fear changed in the study. The body still reacted to trauma reminders in the same way for everyone. This suggests the brain scan helped the thinking part of the brain more than the body part.

Experts say this is still a very promising start for the field. It shows that targeting the right circuit can make a real difference. However, the study was small and needs more testing to be sure.

Doctors warn that this is not a cure for everyone. It is a tool that might help some people who have not found relief elsewhere. Patients should talk to their doctors about whether this is right for them.

More research is needed to see if this works for different types of PTSD. Scientists will also look at how long the benefits last over years. Approval from health agencies will take time and more large studies.

For now, this work offers hope for a more tailored way to treat trauma. It moves medicine away from guessing and toward seeing exactly what is happening inside the head. That shift could change how we help people heal from deep emotional wounds.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up6.0 mo
PublishedMay 2026
View Original Abstract ↓
OBJECTIVE: Transcranial magnetic stimulation (TMS) has shown promise in reducing posttraumatic stress disorder (PTSD) symptoms, with varied clinical results. A mechanistic understanding is needed to personalize treatment and improve response rates. The threat neurocircuitry, specifically the right amygdala, has consistently been implicated in PTSD pathophysiology. This neuroscience-informed trial aimed to modulate the threat neurocircuitry using functional MRI (fMRI)-guided TMS to treat PTSD. METHODS: In a double-blind clinical trial, 50 adults with PTSD symptoms were randomized to 10 twice-daily sessions of either 1-Hz TMS or sham TMS. TMS was delivered to an fMRI-guided target within the right dorsolateral prefrontal cortex with the strongest functional connection to the right amygdala. The primary outcomes were right amygdala threat reactivity, assessed by fMRI, and skin conductance reactivity during trauma recall, measured pre- and post-TMS. The secondary outcomes were hyperarousal and total PTSD symptoms (based on the PTSD Checklist for DSM-5), measured pre- and post-TMS and at a follow-up assessment between 3 and 6 months after TMS. RESULTS: Active TMS significantly reduced right amygdala threat reactivity compared with sham TMS. No significant effect of TMS was observed on skin conductance reactivity. From pre- to post-TMS, significant reductions in hyperarousal and total PTSD symptoms were observed across groups, but no significant differences between groups were observed. From pre-TMS to follow-up, active TMS compared with sham TMS significantly reduced hyperarousal and total PTSD symptoms. Clinical findings were found to be robust in sensitivity analyses. CONCLUSIONS: This is the first clinical trial to demonstrate that personalized fMRI-guided TMS targeting the threat neurocircuitry reduces amygdala threat reactivity and improves long-term PTSD symptoms at follow-up. These findings suggest the potential for a personalized approach to neuromodulation in individuals with PTSD.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.